TrialDiabetes care2026

Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Naveed Sattar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.